Every lot of GHK-Cu / KPV is tested by an independent ISO/IEC 17025-accredited lab in the USA. 99%+ purity isn't a target here. It's the requirement.
Don't take our word for it: test any vial at an accredited lab of your choice. If HPLC purity comes back under 99%, we refund your order and pay for the test.
This is a blend. GHK-Cu and KPV are combined in a single 70 mg vial at 50 mg and 20 mg respectively. GHK-Cu is a copper-binding tripeptide studied in skin-remodelling and matrix research; KPV is the C-terminal tripeptide of α-MSH studied for NF-κB pathway suppression. The pairing places a matrix-remodelling arm and an inflammatory-signalling arm in one vial. The combination has not been characterised as a single formulation.
The numbers that define GHK-Cu / KPV and how it is being studied. For laboratory research use only.
2
Research Peptides
GHK-Cu · KPV
70 mg
Total Per Vial
50 mg GHK-Cu + 20 mg KPV
NF-κB
KPV Pathway Target
Inflammatory signalling regulator
4
Research Areas
Skin remodelling
Inflammatory signalling
Wound models
How It Works
How GHK-Cu / KPV works
The pathways GHK-Cu / KPV acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Copper Transport & Matrix Remodelling
GHK-Cu
GHK-Cu is a copper-binding tripeptide. Collagen and glycosaminoglycan synthesis endpoints are characterised in dermal fibroblast culture, alongside copper-transport activity.
Copper-binding tripeptide
Collagen synthesis endpoints
Dermal fibroblast models
Inflammatory Pathway Suppression
KPV
KPV is the C-terminal tripeptide of α-MSH. Lower NF-κB and MAP-kinase pathway activation is measured in vitro at nanomolar concentrations, alongside reduced TNF-α and IL-6 secretion.
α-MSH C-terminal fragment
NF-κB pathway suppression
Cytokine secretion endpoints
Matrix and Inflammatory Arms
Combined
The vial pairs a matrix-remodelling arm with an inflammatory-signalling arm. Both are characterised separately; no interaction data exists for the pair.
Two complementary arms
Matched handling
Interaction not characterised
Uses & Applications
What GHK-Cu / KPV is researched for
The main areas GHK-Cu / KPV is being studied for - and the study-reported figures behind them.
Dermatology
Skin Remodelling Models
GHK-Cu is characterised for collagen and glycosaminoglycan synthesis in dermal fibroblast culture.
Immunology
Inflammatory Signalling
KPV is studied for NF-κB pathway suppression and cytokine secretion endpoints.
Dermatology
Wound Closure Models
Both peptides appear in wound-model literature from different mechanistic angles.
Methods
Parallel Protocols
One vial holds both peptides under matched handling.
Study-reported magnitudes
Representative figures from published research. Bars fill as you scroll.
GHK-Cu Collagen EndpointsCharacterised
KPV NF-κB ActivationInhibited
Cytokine Secretion EndpointsMeasured
Blend Interaction DataNone
Figures are representative of published research findings and shown for reference.
Molecular Structure
The GHK-Cu / KPV molecule
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Molecular model
Sequence length
blend
Physical form
Lyophilized powder blend
Documented purity
≥99% by HPLC
Compound Information
Full specification
Components
GHK-Cu + KPV
Content
70 mg per vial (50 mg GHK-Cu + 20 mg KPV)
GHK-Cu Sequence
Gly-His-Lys (copper complex)
KPV Sequence
Lys-Pro-Val (α-MSH 11-13)
KPV Molecular Weight
342.43 g/mol
Form
Lyophilized powder blend
Purity
≥99% by HPLC
Solubility
Water-soluble
Storage
-20°C, protected from light
Classification
Research use only
FAQ
Common questions about GHK-Cu / KPV
They cover different arms of skin and inflammation research: GHK-Cu for matrix remodelling, KPV for inflammatory signalling. One vial holds both under matched handling.
The formulation is 50 mg GHK-Cu to 20 mg KPV, following the supplier's specification. It is fixed and cannot be varied within the vial.
No. Each peptide is characterised separately and no interaction data exists for the pair.
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
